Recombinant multi-species ERFE protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ERFE protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Predicted to enable hormone activity. Predicted to be involved in several processes, including negative regulation of gluconeogenesis; positive regulation of glucose import; and positive regulation of insulin receptor signaling pathway. Predicted to act upstream of or within positive regulation of fatty acid transport and regulation of fatty acid metabolic process. Predicted to be located in extracellular region. Predicted to be active in extracellular space. [provided by Alliance of Genome Resources, Apr 2022]
The Alternative Names of target: ERFE,Erythroferrone,Complement C1q tumor necrosis factor-related protein 15, Myonectin,CTRP15,FAM132B,C1QTNF15

Target products collectionGo to ERFE products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE0908-Ab-1/ GM-Tg-hg-SE0908-Ab-2 Human ERFE protein Human
GM-Tg-rg-SE0908-Ab-1/ GM-Tg-rg-SE0908-Ab-2 Rat ERFE protein Rat
GM-Tg-mg-SE0908-Ab-1/ GM-Tg-mg-SE0908-Ab-2 Mouse ERFE protein Mouse
GM-Tg-cynog-SE0908-Ab-1/ GM-Tg-cynog-SE0908-Ab-2 Cynomolgus/Rhesus macaque ERFE monoclonal antibody Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE0908-Ab-1/ GM-Tg-felg-SE0908-Ab-2 Feline ERFE protein Feline
GM-Tg-cang-SE0908-Ab-1/ GM-Tg-cang-SE0908-Ab-2 Canine ERFE protein Canine
GM-Tg-bovg-SE0908-Ab-1/ GM-Tg-bovg-SE0908-Ab-2 Bovine ERFE protein Bovine
GM-Tg-equg-SE0908-Ab-1/ GM-Tg-equg-SE0908-Ab-2 Equine ERFE protein Equine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE0908-Ab-1/ GM-Tg-hg-SE0908-Ab-2; GM-Tg-rg-SE0908-Ab-1/ GM-Tg-rg-SE0908-Ab-2;
GM-Tg-mg-SE0908-Ab-1/ GM-Tg-mg-SE0908-Ab-2; GM-Tg-cynog-SE0908-Ab-1/ GM-Tg-cynog-SE0908-Ab-2;
GM-Tg-felg-SE0908-Ab-1/ GM-Tg-felg-SE0908-Ab-2; GM-Tg-cang-SE0908-Ab-1/ GM-Tg-cang-SE0908-Ab-2;
GM-Tg-bovg-SE0908-Ab-1/ GM-Tg-bovg-SE0908-Ab-2; GM-Tg-equg-SE0908-Ab-1/ GM-Tg-equg-SE0908-Ab-2
Products Name ERFE protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name ERFE
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ERFE protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.